期刊论文详细信息
Frontiers in Pharmacology | |
Serratiopeptidase, A Serine Protease Anti-Inflammatory, Fibrinolytic, and Mucolytic Drug, Can Be a Useful Adjuvant for Management in COVID-19 | |
Niraj Kumar Jha1  Charu Sharma2  M. F. Nagoor Meeran3  Shreesh Ojha3  Chandragouda R. Patil4  Sameer N. Goyal5  | |
[1] Department of Biotechnology, School of Engineering and Technology (SET), Sharda University, Greater Noida, India;Department of Internal Medicine, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates;Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates;Department of Pharmacology, Delhi Pharmaceutical Sciences and Research University, New Delhi, India;Shri Vile Parle Kelavani Mandal’s Institute of Pharmacy, Dhule, India; | |
关键词: COVID-19; infection; inflammation; immunomodulators; serratiopeptidase; drug repurposing; | |
DOI : 10.3389/fphar.2021.603997 | |
来源: DOAJ |
【 授权许可】
Unknown